bioRxivCancer Biology
Kinetics characterization of ASXL1/2-mediated allosteric regulation of BAP1 deubiquitinase
H. Peng, J. Cassel, D. McCracken, J. W. Prokop, P. R. Collop, A. Polo, S. Joshi, J. P. Mandell, K. Ayyanathan, D. Hinds, S. B. Malkowicz, J. W. Harbour, A. M. Bowcock, J. Salvino, E. J. Kennedy, J. R. Testa, F. J. Rauscher
Abstract
BAP1 is a ubiquitin hydrolase whose deubiquitinase activity is mediated by polycomb group-like protein ASXL2. Cancer-related mutations/deletions of BAP1 lead to loss-of-function either by directly targeting the catalytic (UCH) or ULD domains of BAP1, the latter disrupts binding to ASXL2, an obligate partner for BAP1 enzymatic activity. However, the biochemical and biophysical properties of the domains involved in forming the enzymatically active complex are unknown. Here we investigate the molecular dynamics, kinetics and stoichiometry of these interactions. We demonstrate that the BAP1 and ASXL2 domain/proteins or protein complexes produced in either bacteria or baculovirus are structurally and functionally active. The interaction between BAP1 and ASXL2 is direct, specific, and stable to in vitro biochemical and biophysical manipulations as detected by isothermal titration calorimetry, GST association, and optical biosensor assays. Association of the ASXL2-AB box greatly stimulates BAP1 deubiquitinase activity. A stable ternary complex can be formed comprised of the BAP1-UCH, BAP1-ULD, and ASXL2-AB domains. Binding of the BAP1-ULD domain to the ASXL2-AB box is rapid, with fast association and slow dissociation rates. Stoichiometric analysis revealed that one molecule of the ULD domain directly interacts with one molecule of the AB Box. Real-time kinetics analysis of ULD/AB protein complex to the UCH domain of BAP1, based on SPR, indicated that formation of the ULD/AB complex with the UCH domain is a single-step event with fast association and slow dissociation rates. These structural and dynamic parameters implicate the possibility for future small-molecule approaches to reactivate latent wild-type UCH activity in BAP-mutant malignancies.
- assay: protein structure
- research focus: protein folding & dynamics
- approach: biophysical modeling
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The BAP1 deubiquitinase complex is a general transcriptional co-activator
Antoine Campagne, Dina Zielinski, … Raphaël Margueron·bioRxiv·Jan 8, 2018
- Proteomic analysis identifies novel binding partners of BAP1
R. Baas, F. J. van der Wal, … T. K. Sixma·bioRxiv·Mar 3, 2021
- Structural basis of histone H2A lysine 119 deubiquitination by Polycomb Repressive Deubiquitinase BAP1/ASXL1
J. F. Thomas, M. I. Valencia-Sanchez, … K.-J. Armache·bioRxiv·Feb 23, 2023
- Unique Gluing Effect of ASXL1 K351 Monoubiquitination Stimulates PR-DUB-Mediated Nucleosomal H2AK119Ub Deubiquitination
Tianyi Zhang, Jiqing Zheng, … Lei Liu·bioRxiv·Apr 25, 2025
- In vitro characterization of the baker's yeast deubiquitinase Ubp3
Lars Bostelmann-Arp, Sakshi Khosa, … Lutz Schmitt·bioRxiv·Aug 20, 2026
- Allosteric control of Ubp6 and the proteasome via a bidirectional switch
K. Y. S. Hung, S. Klumpe, … D. Finley·bioRxiv·Jul 16, 2021